Assembly Biosciences, Inc. Contract Liability (Deferred Revenue)
Assembly Biosciences, Inc. (ASMB) had Contract Liability (Deferred Revenue) of $16.30 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2026-08-13
- 2026-06-30: Contract with Customer, Liability, Current $16.30M.
- 2026-03-31: Contract with Customer, Liability, Current $29.08M.
- 2025-12-31: Contract with Customer, Liability, Current $36.90M.
- 2025-09-30: Contract with Customer, Liability, Current $42.36M.
| Period end | Contract with Customer, Liability, Current | Contract with Customer, Liability, Current as first filed |
|---|---|---|
| 2026-06-30 | $16.30M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $29.08M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $36.90M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $42.36M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $40.92M 10-Q · filed 2025-08-06 | |
| 2025-03-31 | $40.82M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $37.62M 10-K · filed 2026-03-19 | |
| 2024-09-30 | $32.62M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $33.06M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $32.77M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $30.91M 10-K · filed 2025-03-20 | |
| 2020-03-31 | $6.71M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $6.41M 10-K · filed 2021-02-25 | |
| 2019-09-30 | $6.15M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $39.66M 10-Q · filed 2019-08-05 | |
| 2018-12-31 | $5.10M 10-K · filed 2020-03-04 | $40.66M 10-Q · filed 2019-08-05 |
| 2018-06-30 | $43.59M 10-Q · filed 2019-08-05 | |
| 2017-12-31 | $45.78M 10-Q · filed 2019-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |